Denmark· DK-28106022317
Buprenorphin/Naloxon "Viatris"
A buprenorphin, kombinationen product containing buprenorphinhydrochlorid, naloxonhydrochloriddihydrat, registered in Denmark by Viatris Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Buprenorphin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC N07BC51 (buprenorphin, kombinationen), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Buprenorphin, kombinationen · ATC N07BC51
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- BUPRENORPHINHYDROCHLORID, NALOXONHYDROCHLORIDDIHYDRAT
- Manufacturer
- Viatris Limited
- Country
- Denmark (DK)
- ATC code
- N07BC51
- ATC class
- Buprenorphin, Kombinationen
- Defined daily dose
- 8 mg, SL
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106022317
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07BC51
Buprenorphin, kombinationen, as other registers publish it.
- IrelandBulexin 2 mg/0.5 mg sublingual tabletsPinewood Laboratories Limited
- IrelandBulexin 4 mg/1 mg sublingual tabletsPinewood Laboratories Limited
- IrelandBulexin 8 mg/2 mg sublingual tabletsPinewood Laboratories Limited
- DenmarkBunalictSandoz A/S
- FinlandBunalictSandoz A/S
- FinlandBunalictSandoz A/S
- NorwayBunalictSandoz - København
- DenmarkBunalictSandoz A/S
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b4e9907-019b-4582-8f9e-2fdef6cde539 GET /v1/drugs/3b4e9907-019b-4582-8f9e-2fdef6cde539?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "resoribletter, sublinguale",
"source": "dkma",
"strength": "2+0,5 mg",
"auth_role": "CMS",
"dk_drugid": "28106022317",
"substance": "BUPRENORPHINHYDROCHLORID, NALOXONHYDROCHLORIDDIHYDRAT",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43264"
}See everything about buprenorphin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.